Table 3 Risk factors for recurrence in peritoneal cytology-positive, endometrial carcinoma stage IA patients (univariate and multivariate analysis).

From: Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer

Ā 

N

HR (95% CI)

P-value

HR (95% CI)

P-value

Age (range)

 < 60

107

1

0.014

1

0.088

 ≄ 60

28

3.96 (1.31–11.9)

Ā 

2.86 (0.85–9.56)

Ā 

BMI

 < 25

100

1

0.160

Ā Ā 

 ≄ 25

35

2.28 (0.71–7.20)

Ā Ā Ā 

Histology

Type I

99

1

0.006

1

0.035

Type II

36

4.76 (1.55–14.5)

Ā 

3.56 (1.08–11.6)

Ā 

Tumor size

 ≄ 3Ā cm

78

1

0.153

Ā Ā 

 < 3Ā cm

57

0.44 (0.14–1.35)

Ā Ā Ā 

Surgery

Laparoscopy

17

1

0.152

Ā Ā 

Laparotomy

118

0.38 (0.10–1.43)

Ā Ā Ā 

Myometrial invasion

Without myometrial invasion

43

1

0.54

Ā Ā 

With myometrial invasion

92

0.71 (0.23–2.16)

Ā Ā Ā 

LVSI

present

27

1

0.669

Ā Ā 

absent

108

0.71 (0.16–3.25)

Ā Ā Ā 

Lymphadenectomy

Performed

92

1

0.965

Ā Ā 

No performed

43

0.96 (0.29–3.18)

Ā Ā Ā 

With Adj chemotherapy

58

1

0.781

Ā Ā 

Without Adj chemotherapy

77

1.17 (0.39–3.48)

Ā Ā Ā 
  1. BMI body mass index, LVSI lymphovascular space invasion, Adj Adjuvant.